FDA Panel To Weigh REMS For Jazz's Fibromyalgia Candidate
This article was originally published in The Pink Sheet Daily
Executive Summary
Discussions on sodium oxybate likely to stray into effectiveness of current risk management measures for company's narcolepsy drug Xyrem, which contains the same active ingredient.